Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Giovanni Iolascon, Sergio Giménez & Dorottya Mogyorósi. (2021) A Review of Aceclofenac: Analgesic and Anti-Inflammatory Effects on Musculoskeletal Disorders. Journal of Pain Research 14, pages 3651-3663.
Read now
Read now
Krishna Sanka, Rajeswara Rao Pragada & Prabhakar Reddy Veerareddy. (2015) A pH-triggered delayed-release chronotherapeutic drug delivery system of aceclofenac for effective management of early morning symptoms of rheumatoid arthritis. Journal of Microencapsulation 32:8, pages 794-803.
Read now
Read now
Praveen Kumar Gaur, Suresh Purohit & Shikha Mishra. (2013) Development of aceclofenac nanovesicular system using biomaterial for transdermal delivery: physical characterization, ex vivo, in vivo, and anti-inflammatory studies. Journal of Biomaterials Science, Polymer Edition 24:18, pages 2126-2141.
Read now
Read now
Maha Nasr, Samar Mansour, Nahed D. Mortada & A. A. Elshamy. (2008) Vesicular aceclofenac systems: A comparative study between liposomes and niosomes. Journal of Microencapsulation 25:7, pages 499-512.
Read now
Read now
Erik Legrand. (2004) Aceclofenac in the management of inflammatory pain. Expert Opinion on Pharmacotherapy 5:6, pages 1347-1357.
Read now
Read now
Ernst-Martin Lemmel, Burkhard Leeb, Johan De Bast & Spyros Aslanidis. (2002) Patient and Physician Satisfaction with Aceclofenac: Results of the European Observational Cohort Study (Experience with Aceclofenac for Inflammatory Pain in Daily Practice). Current Medical Research and Opinion 18:3, pages 146-153.
Read now
Read now
Masahito Hatori & Shoichi Kokubun. (1998) The Long-term Efficacy and Tolerability of the New Anti-inflammatory Agent Zaltoprofen in Rheumatoid Arthritis. Current Medical Research and Opinion 14:2, pages 79-87.
Read now
Read now
Articles from other publishers (20)
A. E. Karateev, E. Yu. Pogozheva, V. N. Amirdzhanova, E. S. Filatova & V. A. Nesterenko. (2021) Regular use of non-steroidal anti-inflammatory drugs can effectively control pain and global health in patients with moderate activity of rheumatoid arthritis. Modern Rheumatology Journal 15:2, pages 57-63.
Crossref
Crossref
Mariana Del Grossi Paglia, Marcus Tolentino Silva, Luciane Cruz Lopes, Silvio Barberato-Filho, Lauren Giustti Mazzei, Flavia Casale Abe & Cristiane de Cássia Bergamaschi. (2021) Use of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review and network meta-analysis. PLOS ONE 16:4, pages e0248866.
Crossref
Crossref
A. E. Karateev, E. L. Nasonov, S. I. Glukhova, A. A. Barakat, R. L. Gibadullina, E. A. Ageeva, O. S. Fedorova, T. S. Timofeeva, G. R. Mikhailova & A. E. Nasonova. (2019) Evaluation of efficacy and safety of long-term use of amtolmetin guacil in rheumatic diseases: results of a 9-month observational AURORA study (Amtolmetin guacil: allRussian Register for Osteoarthritis, Rheumatoid arthritis and Ankylosing spondylitis). Rheumatology Science and Practice 57:1, pages 66-74.
Crossref
Crossref
Tae Kim, Subindra Thapa, Da Lee, Seung Chung, Jun Lim, Hyeon Jeong, Chang Song, Youn-Woong Choi, Sang-Min Cho, Kyu-Yeol Nam, Won-Ho Kang, Soyoung Shin & Beom Shin. (2018) Pharmacokinetics and Anti-Gastric Ulceration Activity of Oral Administration of Aceclofenac and Esomeprazole in Rats. Pharmaceutics 10:3, pages 152.
Crossref
Crossref
Pragya Yadav, Vaibhav Rastogi, Mayur Porwal, Prashant Upadhyay & Anurag Verma. (2016) 3(2) Designing and optimization of aceclofenac transdermal films using response surface methodology: investigating the effect of hydrophilic and hydrophobic matrix on ex vivo and in vivo permeation characteristics. Journal of Pharmaceutical Investigation 47:6, pages 541-558.
Crossref
Crossref
Eunyoung Kim, Chunhwa Ihm & Wonku Kang. (2016) Modeling of aceclofenac metabolism to major metabolites in healthy volunteers. Drug Metabolism and Pharmacokinetics 31:6, pages 458-463.
Crossref
Crossref
P. V Markov, G. A Pal’shin & A. N Komissarov. (2014) Efficacy of Analgesic Therapy after Hip and Knee Arthroplasty. N.N. Priorov Journal of Traumatology and Orthopedics 21:1, pages 57-60.
Crossref
Crossref
Mi Jo Kim, Hyeong-Seok Lim, Yook-Hwan Noh, Yo Han Kim, Hee Youn Choi, Kyung-Mi Park, Sei-Eun Kim & Kyun-Seop Bae. (2013) Pharmacokinetic Interactions Between Eperisone Hydrochloride and Aceclofenac: A Randomized, Open-Label, Crossover Study of Healthy Korean Men. Clinical Therapeutics 35:10, pages 1528-1535.
Crossref
Crossref
Eunyoung Kim, Byoungki Ahn, Keumhan Noh, Wonku Kang & Hye sun Gwak. (2012) Quantitative determination of aceclofenac and its three major metabolites in rat plasma by HPLC-MS/MS. Journal of Separation Science 35:17, pages 2219-2222.
Crossref
Crossref
Soo Kyung Bae, Soo-Hwan Kim, Hae Won Lee, Sook Jin Seong, Su-Yeon Shin, Sang Hun Lee, Mi-Sun Lim, Young-Ran Yoon & Hye Jung Lee. (2012) Pharmacokinetics of a New Once-Daily Controlled-Release Formulation of Aceclofenac in Korean Healthy Subjects Compared with Immediate-Release Aceclofenac and the Effect of Food. Clinical Drug Investigation 32:2, pages 111-119.
Crossref
Crossref
Naomi Schlesinger, Marc De Meulemeester, Andrey Pikhlak, A Eftal Yücel, Dominik Richard, Valda Murphy, Udayasankar Arulmani, Peter Sallstig & Alexander So. (2011) Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study. Arthritis Research & Therapy 13:2.
Crossref
Crossref
Sandra Pérez & Damià Barceló. (2008) First Evidence for Occurrence of Hydroxylated Human Metabolites of Diclofenac and Aceclofenac in Wastewater Using QqLIT-MS and QqTOF-MS. Analytical Chemistry 80:21, pages 8135-8145.
Crossref
Crossref
Si-Youn Rhim, Jin-Hee Park, Yoo-Sin Park, Min-Ho Lee, Leslie M. Shaw & Ju-Seop Kang. (2008) Bioequivalence and pharmacokinetic evaluation of two branded formulations of aceclofenac 100 mg: a single-dose, randomized, open-label, two-period crossover comparison in healthy Korean adult volunteers. Clinical Therapeutics 30:4, pages 633-640.
Crossref
Crossref
Wonku Kang & Eun-Young Kim. (2008) Simultaneous determination of aceclofenac and its three metabolites in plasma using liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 46:3, pages 587-591.
Crossref
Crossref
Angelo Zinellu, Ciriaco Carru, Salvatore Sotgia, Emanuela Porqueddu, Paolo Enrico & Luca Deiana. (2005) Separation of aceclofenac and diclofenac in human plasma by free zone capillary electrophoresis using N-methyl-d-glucamine as an effective electrolyte additive. European Journal of Pharmaceutical Sciences 24:4, pages 375-380.
Crossref
Crossref
Burkhard Hinz, Daniel Auge, Thomas Rau, Stephan Rietbrock, Kay Brune & Ulrike Werner. (2003) Simultaneous determination of aceclofenac and three of its metabolites in human plasma by high‐performance liquid chromatography. Biomedical Chromatography 17:4, pages 268-275.
Crossref
Crossref
David Gurwitz & Abraham Weizman. (2002) The NR2B subunit of glutamate receptors as a potential target for relieving chronic pain: prospects and concerns. Drug Discovery Today 7:7, pages 403-406.
Crossref
Crossref
Mukta Dooley, Caroline M. Spencer & Christopher J. Dunn. (2001) Aceclofenac. Drugs 61:9, pages 1351-1378.
Crossref
Crossref
Albrecht Wiebalck, Roman Dertwinkel & Michael Zenz. (1998) 2a NSAIDs and other non-opioids in chronic pain. Baillière's Clinical Anaesthesiology 12:1, pages 19-38.
Crossref
Crossref
A. Del Favero. 1997.
86
102
.